Month: October 2018

MRI Reveals How Neurostimulation Can Treat GI Disorder

Though it may come as a surprise to some, there are a number of gastrointestinal conditions that can be treated using electrical nerve stimulation. The stomach, for example, can be motivated to empty by neurostimulating the vagus nerve to treat gastroparesis in patients with diabetic autonomic neuropathy and others. While this has been known for […]

Medtronic’s myPTM Smartphone Controller for SynchroMed II Pain Drug Pump Approved by FDA

Medtronic landed an FDA approval for its myPTM smartphone-powered controller for the SynchroMed II drug delivery system. The new product allows pain patients with the implanted SynchroMed II device to deliver a bolus of the medication into their bodies, precisely when needed. The patient’s physician can set limits on how much of the drug can be […]

NovioSense Announces Positive Clinical Trial Results of Tear Glucose Measurement Technology

NovioSense has demonstrated the measurement of tear glucose in diabetic patients and a close correlation to blood glucose with clinically relevant accuracy. A second, 24-patient study, to validate the use of the new glucose sensor in type 1 diabetic patients is already commencing. NovioSense BV, a company based in The Netherlands, announced positive data from its […]

Microfluidic Chips to Diagnose and Characterize Cancer: Interview with Prof. Fatih Sarioglu, Georgia Tech

Research into microfluidic devices to aid in cancer diagnosis promises huge leaps in making diagnostics easier and faster. Much of this research is focused on chips that can trap circulating tumor cells (CTCs) which are present in blood samples. CTCs are released from a primary tumor and can form metastases in other sites in the […]